These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2617738)

  • 1. [The morphofunctional damage to the biomembranes in the lipid peroxidation syndrome in patients with the terminal stage of chronic kidney failure].
    Grinshteĭn IuI; Linev KA
    Urol Nefrol (Mosk); 1989; (6):45-8. PubMed ID: 2617738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Status of the antioxidant system and free radical lipid peroxidation in patients with chronic renal failure].
    Grinshteĭn IuI; Andrianova GP
    Ter Arkh; 1988; 60(6):54-6. PubMed ID: 3206371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lipid peroxidation as a possible mechanism of erythrocyte damage in patients with chronic kidney failure on hemodialysis].
    Balashova TS; Rud'ko IA; Ermolenko VM; Tsalenchuk IaP; Kubatiev AA
    Ter Arkh; 1992; 64(6):66-9. PubMed ID: 1440343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure].
    Grinshteĭn IuI; Tereshchenko VP; Tereshchenko IuA; Romanova VIa
    Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of hemodialysis on lipid peroxidation].
    Stetsiuk EA; Khokhlov AP; Siniukhin VN; Ivanov VE; Iarmolinskiĭ IS
    Urol Nefrol (Mosk); 1989; (4):47-50. PubMed ID: 2800078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Free radical oxidation and tubular dysfunctions in patients with chronic kidney failure].
    Grinshteĭn IuI; Lundina TA; Knubovets TL; Sibel'dina LA; Sedov KR
    Ter Arkh; 1991; 63(6):62-5. PubMed ID: 1948750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell membrane lipid peroxidation and chronic haemolysis in haemodialysis patients.
    Taccone-Gallucci M; Lubrano R; Mazzarella V; Bandino D; Meloni C; Morosetti M; Elli M; Giardini O; Boffo V; Tozzo C
    Life Support Syst; 1985; 3 Suppl 1():41-4. PubMed ID: 3870599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis].
    Paul JL; Man NK; Moatti N; Raichvarg D
    Nephrologie; 1991; 12(1):4-7. PubMed ID: 2034320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
    Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
    Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Functional destabilization of the cell membranes in the pathogenesis of opisthorchiasis].
    Nalobin AV; Zhmurov VA; Nalobin VA; Liaĭkht EI
    Med Parazitol (Mosk); 1991; (2):13-5. PubMed ID: 2067485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell lipid peroxidation in predialysis chronic renal failure.
    Taccone-Gallucci M; Giardini O; Lubrano R; Bandino D; Mazzarella V; Mannarino O; Meloni C; Morosetti M; Elli M; Tozzo C
    Clin Nephrol; 1987 May; 27(5):238-41. PubMed ID: 3594939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis].
    Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT
    Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The erythrocyte pro-oxidant and antioxidant systems of patients with chronic kidney failure].
    Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
    Ter Arkh; 1995; 67(8):7-9. PubMed ID: 7482345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
    Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K
    Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid metabolic disorders and lipid peroxidation in patients with the nephrotic syndrome].
    Shishkin AN; Kolmakova EV; Ashirova KV
    Urol Nefrol (Mosk); 1994; (3):39-41. PubMed ID: 8079411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation.
    Koenig JS; Fischer M; Bulant E; Tiran B; Elmadfa I; Druml W
    Wien Klin Wochenschr; 1997 Jan; 109(1):13-9. PubMed ID: 9037743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
    Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hemodialysis on the deformability and lipid peroxidation of erythrocytes in chronic renal failure.
    Szikszai Z; Ujhelyi L; Imre SG
    Clin Hemorheol Microcirc; 2003; 28(4):201-7. PubMed ID: 12897411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of dialysis membranes on lipid peroxidation in erythrocytes of patients with terminal renal failure].
    Kubatiev AA; Rud'ko IA; Balashova TS; Ermolenko VM
    Biull Eksp Biol Med; 1994 Nov; 118(11):460-2. PubMed ID: 7888639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.